Hormone replacement therapy with estrogen

Hormone replacement therapy with estrogen has been studied in 1 paper since 2020: none in people yet, 1 review. No study of it in people or animals has been published yet. The newest paper, Apr 7, 2020: “Medications as a Risk Factor for Fragility Hip Fractures: A Systematic Review and Meta-analysis”.

Intervention

1 paper studies it1 findingUpdated

See all 1 papers on hormone replacement therapy with estrogen

At a glance

The findings reach people, from one lab or study. 1 lab in 2 countries.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 2 countries

What is hormone replacement therapy with estrogen linked with?

1

Studies link hormone replacement therapy with estrogen with fragility hip fracture.

Fragility hip fracture

downin humans1OR 0.8

1 study
  1. Hormone replacement therapy with estrogen lowers the risk of fragility hip fracture in humans (OR 0.80, 95% CI 0.65-0.98).

    “Hormone replacement therapy with estrogen (HRT) was associated with decreased risk of hip fracture (OR 0.80, 95% CI 0.65-0.98).”

    Review

    Medications as a Risk Factor for Fragility Hip Fractures: A Systematic Review and Meta-analysis

    Calcified tissue international

More on Fragility hip fracture

Latest